Managing Director & Partner, BCG X
Nate Beyor is part of the West Coast leadership team for the Health Care practice at Boston Consulting Group, and an expert on R&D and operations in health care. He leads BCG's Health Tech Initiative to engage tech natives in health care—from growth startups to large tech brands. Nate joined BCG’s Digital Ventures business unit with a focus on building digital health solutions with clients. He has shepherded teams toward product and startup launches in R&D, data monetization, supply chain, and patient engagement.
Nate’s work is focused on the interface between technology and biology, and is backed by operational rigor. He has spent his career exploring different avenues at this intersection, including microfluidics, biologics manufacturing, stem cell therapy development, and now digital health. Nate believes in the power of technology to change how we treat, heal, and live. He has led joint BCG-client teams to launch seven digital software solutions into the market,
Before joining the firm, Nate was Vice President of Corporate Development at Asterias Biotherapeutics, a cell therapy company, where he led development partnering and IP licensing as well as internal initiatives across finance and digital. Prior to that, he was an Associate Partner at McKinsey & Company, where he was a leader in the Pharmaceutical and Medical Products Operations Practice. Nate also founded several startups in medtech and technology, where he gained experience in fundraising, lean product development, and first customer acquisition.
Here’s what to keep in mind when developing and commercializing software as a medical device.
The Digital Health Summit, produced by Living in Digital Times, convenes one of the broadest spectrum of health care and technology audiences in the world. The Summit features innovations and advancements in genomics, diagnostics, wearables, telehealth and more in the mobile health market. This is a must see event each year that takes place at the International Consumer Electronics Show (CES) in Las Vegas.
Watch the full video
The COVID-19 crisis changing the way we live and work, and having a huge impact on technology and business. With this in mind, we’re putting out a series of short Buildcast episodes covering how different sectors are responding.
Watch the full video.
Once a digital therapeutics (DTx) company has determined the kind of value its software as a medical device (SaMD) provides, it needs to figure out which regulatory and commercialization strategies make the most sense.
As DTx comes of age, there are an increasing number of important questions about sources of value and product development programs.
Virtual reality platforms provide engaging experiences and can track user metrics -- both of which are a boon to health care.
New technologies are transforming the pharmaceutical industry’s approach to R&D. What’s happening now in the field—and what’s coming next?
In our “Amazon Prime” world, consumers demand instant gratification. Hear from leaders across the medical spectrum—pharma, medtech, and payers and providers—about how new-age digital hubs bridge the gap between health tech and adoption, engaging and creating client communities via a seamless, personalized experience.